drugset / Trial / NCT01776203

Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist

NCT01776203

Phase 4 Terminated 8 enrolled Kaiser Permanente
RandomizedSingle-groupOpen-labelTreatment

Summary

In this study, the investigators would like to see if giving medroxyprogesterone acetate for 3 weeks after Leuprolide acetate injection will help to decrease this amount of bleeding, decrease the amount of nausea, bloating and cramping and increase patient satisfaction

Timeline

Start
2012-01
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator medroxyprogesterone acetate Other / unclassified 20 mg Oral

Indications